Preface noted with concern that veterinary pathology has been slow to adapt to progress in the field. Veterinary oncologists will not be able to devise therapies for specific types of lymphoma unless and until veterinary pathologists provide them with a current level of diagnostic detail. The initiatives of the American College of Veterinary Pathologists in a variety of areas of animal oncology, including canine lymphomas, are timely and needed. This book provides both pathologists and oncologists with information to provide more specificity in both diagnosis and therapy of animal hematopoietic neoplasms. The last revision of the WHO system of classifying human hematopoietic neoplasia, now in use for more than a decade, represents both a challenge and an opportunity for veterinary medicine. The major premise of the current WHO revision was that neoplasms were to be defined as diseases based on all available information rather than on cellular criteria. In the late 1990s, while updating the WHO Fascicle on histology of animal hematopoietic neoplasms, we found that the WHO system of hematopoietic disease classification in humans was readily applicable in animals. The utility of this system is immediately apparent. As new criteria define new entities they are added to the list of neoplasms based on characteristics that permit them to be reliably identified. This approach is readily applicable to any species and particularly to those domestic animals in which we most frequently encounter hematopoietic neoplasia. To that end, this first edition of Veterinary Comparative Hematopathology is based on the WHO classification framework on which future developments can logically be added. This textbook follows the philosophy of a noted fellow countryman, William Osler, who recognized that basic phenomena are common to diseases of all species; there is only one medicine.
V.E. Valli, DVM
Veterinary Comparative Hematopathology represents the clinical and research experiences gleaned, as well as the study of many of the cases collected, during 35 years of attempting to better understand and recognize hematopoietic neoplasia. It is appropriate to thank those many colleagues whose names appear in figure legends for their contributions. I did not intend to structure the text as a comparative review but came to this conclusion in response to comments from reviewers who wondered at the volume and level of comparative data contained herein.
This book does not trivialize the importance of hematopoietic neoplasia in animals by presenting them as models of human disease. Rather, this work draws heavily on the major and much more extensive current human literature for information on specific diseases not extant in veterinary publications. The major purpose of this book is to define hematopoietic neoplasms in animals, with comparison to those in humans where reasonable similarities exist to guide classification and understanding. In contrast, those neoplasms now defined in humans that lack a currently recognized animal counterpart are described in the human context and await the identification of a comparable animal neoplasm. This format provides veterinarians with a ready reference to help identify such diseases.
It is increasingly evident that diseases of mammals, particularly neoplasms, have a commonality, with those in humans best studied and understood. Genomic studies in humans and animals have demonstrated a remarkable level of conservation of genes and genetic traits extending across mammalian clades. How then can it be that there are more than 30 defined types of B-and T-cell neoplasms in humans that differ widely in biology and response to therapy, but all of those in dogs can be treated as one disease?
Despite the rapid progress that has occurred in oncology, many of us in diagnostic veterinary medicine have xi xii Acknowledgments scope of this subject and the comparative approach required that assistance was needed from many professionals in both human and veterinary medicine. Their names are gratefully credited in the descriptions of images. Their enthusiastic response to requests for use of images or slides of specific conditions was essential and much appreciated. This book is the result of many hours of concentrated effort at nights and on weekends over more than two years, always with encouragement and support from my beloved spouse Carroll.
In learning our disciplines we stand on the shoulders of those who have taught us and subsequently those who have sent us cases over the years that have shaped our perception and understanding of animal diseases. It is appropriate to recognize their invaluable assistance. More recently the principals at Blackwell Publishing deserve recognition for their guidance and diligent attention to the details of this book and to Nancy Albright for excellent copyediting. A book in preparation needs careful review and especially when written by a single author. I thank those colleagues recognized herein as chapter reviewers for their thoughtful and knowledgeable guidance. The Specific diseases are named to assist their correct recognition. These may be after the people who first described them as in Burkitt's lymphoma and the Reed-Sternberg cell of human Hodgkin's lymphoma. They are also named by the cause, as in the necrotizing laryngitis of diphtheria due to infection with Corynebacterium diphtheriae. Once identified as entities, specific diseases may then be classified as to cause if known, or on cell type(s) involved and observed rate of progression. Hematopathology has progressed through a series of systems for classifying diseases that were based mainly on cellular characteristics. These systems continued to evolve as it was recognized that cells with similar morphology on routine stains might have very different behavior in both normal and neoplastic states. The advantage of a classification system based on diseases is that the total entity is included in the context of a single disease.
The understanding of specific diseases evolved with steady progression in the recognition of subtle differences, such as in the subtypes of Hodgkin's lymphoma. In contrast, classifications based on cell types had many false starts as increased knowledge of cellular biology rendered early assumptions on lineage and activity to be in error. Many names for perceived cell types such as reticulum cell and clasmatocyte have happily been laid to rest as the discipline has advanced in understanding. The evolution in classification of lymphomas has not been without heated discussion, which has had interesting origins in both national preferences and geographic differences in incidence of neoplastic subtypes. But in review, the real reason that lymphoma classifications keep changing is that new understanding of cellular mechanisms drives cell and disease recognition into new categories.
The history of lymphoma classifications is described by Harris and Ferry Brill (1925) , Symmers (1927) , Baehr (1932) , Gall (1941) • Burkitt's lymphoma: Burkitt (1958) , O'Connor (1961) As lymphoid neoplasms were described, attempts were made to put these together in early classifications with the main categories: lymphosarcoma, reticulum cell sarcoma, and Hodgkin's disease. It was recognized that the small cell lymphomas tended to be more slowly progressive than the large cell lymphomas, then known as reticulum cell sarcomas. In 1934, the American Registry of Pathology assembled a list of lymphoid neoplasms divided into lymphocytotic (small cell), lymphosarcoma (medium size cell), and reticulum cell (large cell) groups. The lymphocytotic group had a leukemic subdivision of chronic and acute types and an aleukemic group of diffuse and nodular types. In this system, the lymphosarcomas were divided into aleukemic (solid lymphoma) and leukemic forms. Of these, the large cell or reticulum cell tumors had leukemic reticulocytoma that included monocytic leukemia with an aleukemic form of the same cell types. Finally, reticulum cell sarcoma was retained for the solid large cell neoplasms. In England, Robb-Smith in 1938 devised a very complex list that included both benign and
Chapter 1
The Evolution of Classification Systems for Hematopoietic Neoplasms malignant diseases based on the concept of the reticuloendothelial system. A legacy of that classification is the rather descriptive term histiocytic medullary reticulosis, a form of lymph node medullary sinus histiocytosis.
Gall and Mallory provided a shortened system in 1942 that was based on cell morphology but with distinctive clinical courses based on their 618 cases from Massachusetts General Hospital. Their system divided reticulum cell sarcoma into stem cell and clasmatocytic types and lymphoma into small cell, lymphoblastic, and follicular types followed by Hodgkin's lymphoma and sarcoma. This system came into wide use in the United States and was followed by a classification by Jackson and Parker, first in 1939 and updated in 1947 . The latter system separated Hodgkin's disease into three categories and became widely used as well.
The next major change was initiated by Henry Rappaport, then at the University of Chicago, who studied some 300 cases of lymphoma in U.S. servicemen and concluded that regardless of cell type all lymphoid neoplasms, including Hodgkin's disease, had a better prognosis if accompanied by a nodular or follicular architectural pattern. The Rappaport classification removed the term clasmatocytic and also the follicular lymphoma of Gall and Mallory, which was replaced by four types of nodular lymphoma. The relationship of nodular lymphoma to follicular and to benign proliferation was not accepted. Although the process of lymphocyte "transformation" in culture was then described, the term histiocytic was retained for large cell lymphomas. In addition, the entity of aggressive small cell lymphoblastic lymphoma was lost in combination with diffuse poorly differentiated lymphocytic lymphoma. At this time, small lymphocytes were defined by the term lymphocytic and, as an extension, a slightly larger cell that today is likely to be called lymphocytic intermediate was called poorly differentiated lymphocytic (lymphoma). Thus, while the Rappaport system focused on the importance of architecture and nodularity, it lost the value of recognizing specific diseases such as lymphoblastic lymphoma. The Hodgkin's subtypes were not adequately categorized by nodularity alone and lost the recognition of the entities with lymphocyte depletion and Reed-Sternberg cell predominance. Although now considered a backward step in terms of biological understanding of lymphomas, the Rappaport system became the standard in the United States. This occurred because it required pattern recognition that separated indolent follicular lymphomas from the more aggressive diffuse lymphomas and 40% of adult lymphomas in the United States were of follicular type. On this basis, the Rappaport system could be shown to have "clinical relevance."
Although a major fraction of adult lymphomas were of follicular type, Hodgkin's lymphoma affected both the young and old, and in the United States it accounted for half of all human lymphoma cases. In 1966, Lukes and Butler described a new classification of Hodgkin's disease that separated the granuloma of Jackson and Parker into two subtypes of nodular sclerosis and mixed cellularity and showed that these two categories tended to affect a younger age group. At this time, the lymphocyte predominant types of Hodgkin's disease were shown to be highly radiosensitive and curable and great attention was attached to making the correct tumor categorization. The focus on Hodgkin's disease relegated other lymphomas to a new category of non-Hodgkin's lymphoma.
The growth in research in cell biology and immunology of the 1960s brought new information that had major implications for the understanding and interpretation of lymphoid neoplasms. First, the puzzle of how small lymphocytes, believed to be end-stage cells and unable to divide, could form tumorous masses was solved with the demonstration that they could enlarge and divide in response to mitogens and antigenic stimulation. Secondly, the thymus, long a mystery organ, became of major interest with the recognition that lymphocytes indistinguishable morphologically could be of several lineages based on functional activity. Further, in the 1970s, the antigen receptor capability of these lymphocyte subsets was identified as well as the means to their recognition in both normal and neoplastic populations. With the application of these technologies to the lymphomas, it became clear that a major new stratification was needed based on phenotype in addition to pattern recognition or determination of nodular and diffuse architecture.
The first classification system for lymphomas based on immunological principles was developed by Karl Lennert of Kiel, Germany, and was named the Kiel Classification of 1974. This was revised in 1988 and again in 1992. At this time, there was avid interest in how the cells observed in benign lymphoid proliferation were mimicked in neoplastic states and how the small and large "cleaved" lymphocytes fitted into the stream of lymphoid differentiation occurring in the germinal centers of lymph nodes. Lennert recognized that the lymphoid neoplasms were malignant counterparts of benign cells at various stages of differentiation and devised names accordingly. The small cells were named centrocytes and the large cells named centroblasts following the terminology of hematology, with the youngest form termed a blast cell. (Originally, the terms were germinocyte and germinoblast, but the possible confusion with cells of the developing ovarian follicle recommended the change.)
The Lennert publication was well described and well illustrated and rapidly became the standard in Europe, with a modified system used in the United Kingdom. In the United States, the Lukes and Collins classification of 1974 was also based on a B-/T-cell categorization similar to the Kiel system. The latter system ignored pattern and assumed that cell type, of itself, was the determining factor in predicting clinical progression. The difficulties with this system were that while separation into B-and T-cell types was required, phenotyping was not generally practiced. Further, a single cell category-the follicular center cell lymphoma-contained most of the lymphomas seen. This classification is best remembered for a theoretical scheme of lymphocyte maturation in the normal germinal center from small lymphocyte through small-and large-cleaved cell categories to plasma cells and memory cells, all without phenotypic verification.
The Lukes-Collins system was not popular in the United States and, for that matter, neither was the Kiel classification. Oddly, there were fewer follicular lymphomas in Europe as compared to North America, and although the Kiel classification included pattern or architecture, the terminology was unfamiliar and the system did not seem to place the same emphasis on pattern as the older Rappaport system. In this climate, there arose a profusion of classification systems and it became difficult for pathologists as well as oncologists to communicate about cases of similar cell type.
To bridge this gap in communications, the American National Cancer Institute initiated a study of 1,200 cases of lymphoma from multiple institutions that were reviewed by six leading experts who had proposed classification systems and six other pathologists with expertise in lymphomas. Each pathologist was required to classify all cases by each of the six extant systems. A major determinant was the ability of each system to predict outcome, with the result that none proved superior. Other endpoints were both inter-and intraobserver reproducibility, and these were found to be disappointingly low. There was no consensus on a standard system, and as a result the derived system based on actuarial determined survival was called the Working Formulation for Clinical Usage (1982) . A significant feature of the Working Formulation (WF) was that it divided the list of disease categories into three levels based on survival, which translated into rate of progression. There were difficulties in application of the WF system. The criteria for differentiating the large cell from the large immunoblastic cell lymphomas were not clearly defined. Also, there was overlap in separating the small non-cleaved cells of larger type from the large cell lymphomas of the smaller cell type. Finally, the term small non-cleaved described what the cell was not, but not the characteristics by which it could be recognized. Despite these deficiencies, the WF rapidly became the standard in North America and much of the world except for Europe, where the Kiel classification continued to dominate. Each category of the WF system was given a letter grade A-J that was rapidly adopted by oncologists who regarded them as identifying "treatment groups." In application, the WF system tended to delay recognition of emerging entities, such as MALT, marginal, and mantle cell lymphomas.
In the subsequent decades, new disease entities were described that were not included in the WF system and, in the meantime, immunophenotyping had become universally available and applied. In order to accommodate treatment trials, various study groups and large institutions devised their own modifications of the WF system, with the result that there again arose a problem in communication between institutions and pathologists and oncologists. To address the need for a new coherence in terminology, an international group of 19 hematopathologists from the United States, Europe, and Asia began meeting in 1991 and adopted new criteria for the inclusion of lymphoma categories, which included all the information required to define a distinct disease entity. Thus, the information might include for any category all or some of cellular morphology, phenotype, genotype, and clinical presentation.
The application of these criteria in system development resulted in the Revised European American Classification of Lymphoid Neoplasms (REAL, 1994) (Table 1.1). Subsequently the REAL system was largely adopted with minor changes to the revised Summary of the WHO classification of tumors of the hematopoietic and lymphoid tissues (2000) . The REAL-WHO classification system has been criticized as being a list rather than a ranking of diseases in order of clinical progression but, in effect, it has that attribute as well. However, because each entity listed is accepted as a specific disease, it is feasible and most desirable that the management for each entity is specifically tailored to that entity rather than to a "therapeutic grouping."
In application, the REAL-WHO requires that morphology is the most basic criterion and sufficient for some types of lymphoma, particularly of follicular type where phenotyping and genotyping are not essential. A major advance in the application of the REAL-WHO system is that B-cell CLL (chronic lymphocytic leukemia) and SLL (small lymphocytic lymphoma) are accepted as different manifestations of the same disease, with the emphasis and designation placed on the tissue with the largest burden of tumor. Similarly, in the precursor cell neoplasms, lymphoblastic lymphoma and acute lymphoblastic leukemia are also manifestations of the same neoplasm. In animals where CLL of T-cell type predominates, the same continuity seems to apply for T-cell CLL and SLL and for T-cell ALL (acute lymphoblastic leukemia) and LBL (lymphoblastic lymphoma), at least in dogs.
In some cases, particularly in mediastinal large B-cell lymphoma, it is essential also to have the clinical presentation in order to arrive at a correct diagnosis. Further changes are the recognition that plasma cell myeloma and a Likely to include more than one disease Hodgkin's disease are lymphoid neoplasms of B-cell lineage. Perhaps the most significant comment that may be made on the REAL-WHO system is that, in practical application in review of 1,403 cases of human lymphoma with all required data available in all cases, the review pathologists had an overall agreement rate of greater than 85%. Only 2.8% of the cases were felt to be unclassifiable, largely due to technical factors. Each review pathologist was required to reread 20% of the cases at each study site, as selected at random by the attending statisticians, which produced an agreement rate with their initial diagnosis also of 85% (82-89%). The strategy of case examination required each pathologist to render an initial diagnosis on only the hematoxylin-eosin-stained section. They were then provided with the phenotyping slides or flow data and required to make a second diagnosis. Finally, they were given the clinical history and presentation and then made a third and final diagnosis. This process demonstrated that phenotyping did not significantly increase the diagnostic accuracy for follicular lymphomas, marginal zone B-cell lymphoma of MALT type, and the small lymphocytic and lymphoplasmacytic lymphomas. On the other hand, detailed clinical data was helpful only in distinguishing primary mediastinal B-cell lymphoma from other large B-cell neoplasms. These results need to be verified in a veterinary setting, with each pathologist required to diagnose each case via the three-step system that was used in the human study on the application of the WHO system. Such a study has never been attempted in animal 
LYMPH NODES Normal Form and Function

Embryology
The development of lymph nodes is part of an ancient and highly conserved phylogenetic process whereby mammals have a dual vascular network of blood and lymphatic vessels. In the early embryo, lymphatic vessels differentiate from blood vessels. The first stage of lymphatic development occurs in the cardinal vein of the early embryo as a subset of endothelial cells express the LYVE-1 and VEGFR-3 receptors that are present on normal adult lymphatic channels. As differentiation commences, these endothelial cells express different levels of the homeobox gene Prox-1 and are induced to form buds from the vein that form the primordia of the lymphatic system. These first few lymphatic cells then express the secondary lymphoid chemokine (SLC) and increase expression of VEGFR-3 with both markers of mature lymphatic cells. As the embryo develops, the blood vessels deliver nutrients and later immune cells while the lymphatics collect extravasated leukocytes and fluid and return both to the blood vascular system. Failure of development of these two systems is characterized by congenital arteriovenous malformations resulting in edema and ascites. Knockout mice lacking the early lymphatic signaling genes develop arteriovenous shunts and embryonic hemorrhage. Lymph node development begins as an anastomosis of adjacent lymphatic vessels with an aggregation of surrounding mesenchymal cells and small blood vessels. These associations form an eccentric folding of the vessels and surrounding mesenchyme that form the framework for the node with the capsule and afferent and efferent vessels. Studies conducted by injection of vessels with polymer followed by corrosion demonstrate that the hilar arterioles form many fine branches in the deep cortex that arborize in the outer cortex around the primordial germinal centers, which are themselves relatively avascular. The veins form in parallel with the arterial system and exit at the hilar pole with efferent lymphatics. All venules except those in the inner cortex have a low endothelial lining with fenestration of some medullary capillaries, but all others have a complete endothelial lining with basement membrane and pericytes.
Small and medium lymphocytes enter the area within 2 days after the initial formation at 18-19 days in the rabbit embryo. There is a slow increase in lymphocyte numbers with the early formation of nodular organization evident just prior to birth. In the dog, the organization of the lymph nodes follows that of the thymus and the spleen at 35-38 days and lymphocytic colonization is well advanced at 52-53 days. The ontogeny of immune competence varies widely with species, but generally welldeveloped germinal centers with antigen-related polarity are not present at birth unless there has been intrauterine infection as occurs in foals aborted at term with equine viral rhinopneumonitis (EVR) virus infection.
Structure
Lymph nodes having a dual vascular structure have cellular feed-in from both the lymphatic and the blood systems. Lymphatic drainage brings in antigenically charged cells from the tissues as well as antigen in various forms and, in some cases, neoplastic cells primarily from carcinomas. The vessels bring lymphocytes that are naive and recycled; these are able to enter the node cortex via the intercellular adhesion molecules (ICAMs) that permit cellular adhesion and transluminal migration across the postcapillary venules at specifically determined sites. These vascular structures of the blood and lymphatic channels form three endothelial-lined systemsintravascular, intralymphatic, and interstitial-by which the structure of nodes filter lymph, process antigen, and return lymphocytes from blood to tissue. The major anatomic regions of the lymph nodes are the containing capsule with afferent lymphatics (Fig. 2.1 ) and, progressing inward, the peripheral sinus, the outer and inner cortex, and the medulla containing the fixed cells of the cords surrounded by the sievelike structure of the sinuses that drain into the efferent lymphatics that surround the blood vessels at the hilar area of the node (Fig. 2.2 ). These Chapter 2
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relationships apply in domestic mammals except the pig, where the internal regions of the nodes are inverted with the afferent lymphatics entering in the center of the node surrounded by the cortex and germinal centers with the medullary structures in the periphery (Fig. 2.3) . Like other animals, the recirculating lymphocytes enter the cortical area by migration through high endothelial venules (Fig.  2.4 ), but after residence in B-or T-cell architectural areas, they are returned to the blood by the venous system rather than by efferent lymphatics.
The supporting connective tissue superstructure of the node is of mature collagen that extends in fine supporting columns from the capsule to form larger aggregations in the medullary area that surrounds the hilar vessels (Fig.  2.5) . In nodes that have increased rapidly in size, as occurs in lymphoma and lesser in acute inflammation, the node capsule is thinned and taut and compresses the peripheral sinus in formalin-fixed specimens (Fig. 2.6 ). In contrast, in atrophic states caused by chemotherapy or cachexia, the node capsule is thickened and wavy and the peripheral sinus may be wide and open (Fig. 2.7) . In conjunction with these changes at the outer areas of the node, the supporting raphe become thin and widely separated in hyperplastic nodes and in lymphoma (Fig. 2.8) ; in chronic inflammation they become greatly increased in volume and may dominate the medullary areas of the node (Fig.  2.9 ) Such changes are seen in submandibular lymph nodes of dogs with chronic periodontal disease and in the supramammary nodes of dairy cattle with chronic mastitis. The proliferation of connective tissue of chronic benign lymphadenopathy may be accompanied by follicular hyperplasia or lymphoma, but in either case, it is clear evidence of a long period of intense antigenic stimulation that preceded the current condition.
The cortex of the node contains the germinal centers with mantle, and in hyperplastic states, the outer rim of marginal zone cells (Fig. 2. 10) The germinal centers are surrounded by the T-cell rich outer cortex (Fig. 2.11 ) that contains a mixture of cells, primarily small T-lymphocytes In hyperplasia and lymphoma, the supporting collagenous structures become thinned and widely spaced as the parenchyma is increased in volume. These changes are similar to those seen in the spleen with thinning of the capsule and greater distance between the muscular trabeculae in a distended organ.
with a few blasts and large pale nuclei of dendritic cells, a few macrophages, and the high endothelial postcapillary venules (Fig. 2. 12) The node cortex may itself wax and wane in a focal manner with the medullary sinuses extending to the peripheral sinus in areas of cortical atrophy adjacent to large diffuse areas of cortical hyperplasia, termed deep cortical units (Fig. 2.13) . Changes of this type are typical of the mesenteric nodes in mature rats. The reactivity of the node is segmental and related to the level and type of drainage from a particular efferent lymphatic. Experimentally, ligation of an efferent lymphatic results in atrophy of the underlying area of node cortex. Both antigenic stimulation and the presence of antigen-focusing cells are essential in the incoming lymph for the development and maintenance of the cortical and paracortical reactive units. In early stimulation of nodes, there is a regular sequence of cellular events that progresses over about 10-14 days from initiation to the appearance of well-formed germinal centers. In the early stages of reaction, the paracortex and cortex have a moth- eaten appearance at an architectural level of examination due to a very mixed small and large cell population with many large tingible body macrophages (Fig. 2.14) . As antigen processing develops, a follicular pattern becomes dominant. The timing of these changes has been determined in detail in laboratory primates by serial removal of the axillary nodes after intrabrachial vaccination. That study was undertaken to assist in avoiding an erroneous diagnosis of lymphoma in children given routine immunization and then presented later with axillary lymphadenopathy but lacking the history of vaccination. The time to a follicular pattern in humans is closer to 2 weeks; in dogs given distemper hepatitis vaccination into the caudal footpad followed by serial removal of the popliteal node, the time to follicular development was nearer to 10 days.
Germinal centers are confined to the outer cortex in nodes receiving moderate antigenic stimulation and may populate the inner or paracortex with strong and sustained stimulation. In conditions resulting in follicular hyperplasia, the germinal centers may impinge upon the medullary cords and sinuses that are then compressed into a small area in the center or hilar region of the node (Fig.  2.15 ). The germinal centers have a consistent architecture, with the interior cells having a superficial or light pole and a deep or dark pole that is always oriented with the light pole directed at the source of antigen (Fig. 2.16 ). Recognition of this polarity of germinal centers is an important observation in distinguishing follicular hyperplasia from follicular lymphoma. The superficial pole of the germinal centers is composed primarily of small lymphocytes, with a moderate amount of lightly stained cytoplasm giving that area a less dense appearance when observed at low magnification ( Fig. 2.17) . In contrast, the cells of the deep pole are primarily large lymphocytes with proportionately less cytoplasm that is very deeply amphophilic on hematoxylin and eosin staining, resulting in that area appearing much darker and more dense in comparison to the light zone (Fig. 2.18) . In roughly the geographic center of the follicle, many large macrophages with ingested nuclear debris reside constituting the tingible or stainable body phages (Fig. 2.19 ). These phages are ingesting lymphocytes whose mutation of the variable portion of the immunoglobulin gene has produced an antibody felt to be of too high or too low avidity and which has not been "rescued" from apoptosis by the intrafollicular managerial T-cells in the process of immune cell selection. This anatomy of the germinal center can best be seen in the outer subcapsular area where the orientation of the polarity to the incoming antigen in the peripheral sinus is most apparent.
The mantle cell cuff surrounding the germinal centers tends to be elliptical and of greatest depth over the apical or light pole of the follicle. The mantle cells are a relatively homogeneous population of small lymphocytes that have round compact nuclei that lack nucleoli and have very little cytoplasm resembling those of the thymic cortex (Fig. 2.20) . Although similar in appearance, the mantle cells are functionally heterogeneous and primarily naive pregerminal center B-cells. About 10% of the mantle cells are similar-appearing small T-lymphocytes. The width and density of the mantle cell cuff are indications of the adequacy of host lymphocyte production kinetics. Animals mounting a robust humoral immune response have mantle cell cuffs that completely encircle the germinal center in wide and densely packed cellular columns. In contrast, with persistent stimulation and immune system depletion, the mantle cell cuffs become thinned, discontinuous, and with less dense cellular packing (Fig. 2.21 ). If follicular regression continues, the residual mantle cells collapse into the area occupied by the dendritic cells and appear histologically as clusters of small dark cells against the cortical background. As such they are referred to as "fading" or "inverted" follicles (Figs. 2.22, 2.23). Their recognition is important because if numerous, they indicate a history of follicular hyperplasia that has been superseded by atrophy or lymphoma. In addition, the residual mantle cells provide an orientation to lesions characterized by marginal zone hyperplasia or marginal zone lymphoma. In addition, follicular involution may be followed by cortical and paracortical proliferation of neoplastic small T-cells producing an architectural image remarkably similar to marginal zone lymphoma but having cytologic and lineage specificity.
Marginal zone cells are generally not prominent in normal nodes and, in follicular hyperplasias, may become large and tend to be most numerous over the light pole and sides of the germinal centers and mantle cells (Figs. 2.24, 2.25). The marginal zone cells are most often expanded in the dog and lesser in other domestic animals. Cytologically, the marginal zone cells have round nuclei about 1.5 red cells in diameter and have a fine dispersed chromatin pattern (Fig. 2.26 ). In contrast, in neoplastic proliferation, these cells have the chromatin peripheralized or marginated against the nuclear membrane. Their most defining feature is a prominent single central nucleolus (Figs. 2.27, 2.28). The cytoplasm is relatively abundant and is lightly stained resulting in relatively low density of cellular packing that is most apparent at an architectural level of histologic examination (Fig. 2.29) . In hyperplasia, the marginal zone cuffs tend to be cytologically heterogeneous with admixed cells of the paracortex. The marginal zone cells may be waxing, while the mantle cells are waning with a thin layer of mantle cells around the germinal center serving to identify the outer layer of cell proliferation as of marginal zone type. In marginal zone lymphoma, the perifollicular areas of cellular proliferation become cytologically homogeneous and may penetrate the fading germinal centers on the inside while coalescing with adjacent expanding areas on the outer side. A remarkable and important feature of the marginal zone cells is that in both hyperplastic and neo- 
